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Abstract
Background
Behavioural disorders and psychological symptoms of Dementia (BPSD) are commonly ob-
served in Alzheimer’s disease (AD), and strongly contribute to increasing patients' disability.
Using voxel-lesion-symptommapping (VLSM), we investigated the impact of white matter
lesions (WMLs) on the severity of BPSD in patients with amnestic mild cognitive impairment
(a-MCI).
Methods
Thirty-one a-MCI patients (with a conversion rate to AD of 32% at 2 year follow-up) and 26
healthy controls underwent magnetic resonance imaging (MRI) examination at 3T, including
T2-weighted and fluid-attenuated-inversion-recovery images, and T1-weighted volumes. In
the patient group, BPSD was assessed using the Neuropsychiatric Inventory-12. After
quantitative definition of WMLs, their distribution was investigated, without an a priori ana-
tomical hypothesis, against patients’ behavioural symptoms. Unbiased regional grey matter
volumetrics was also used to assess the contribution of grey matter atrophy to BPSD.
Results
Apathy, irritability, depression/dysphoria, anxiety and agitation were shown to be the most
common symptoms in the patient sample. Despite a more widespread anatomical distribu-
tion, a-MCI patients did not differ from controls in WML volumes. VLSM revealed a strict as-
sociation between the presence of lesions in the anterior thalamic radiations (ATRs) and
the severity of apathy. Regional grey matter atrophy did not account for any BPSD.
Conclusions
This study indicates that damage to the ATRs is strategic for the occurrence of apathy in
patients with a-MCI. Disconnection between the prefrontal cortex and the mediodorsal
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and anterior thalamic nuclei might represent the pathophysiological substrate for
apathy, which is one of the most common psychopathological symptoms observed
in dementia.
Introduction
Amnestic mild cognitive impairment (a-MCI) is defined as a clinical condition characterized
by memory deficits in isolation or associated with additional cognitive dysfunctions in the ab-
sence of dementia [1]. In a proportion of cases, a-MCI is associated with an increased risk for
conversion to dementia in a short time, and is therefore regarded as a “prodromal” stage of
Alzheimer’s disease (AD) [2]. In MCI, cognitive deficits as assessed by neuropsychological in-
struments have, by definition, to be present, thus allowing fulfillment of current diagnostic
criteria [3]. In addition, behavioural disorders and psychological symptoms of Dementia
(BPSD) are also frequently observed in the AD spectrum [4] with depression, apathy and irri-
tability as the most frequent manifestations [5]. BPSD has been shown to have a strong impact
upon patients’ disabilities and quality of life [6], and previous studies have supported the hy-
pothesis that neuropsychiatric symptoms, particularly depression, apathy, and anxiety, are as-
sociated with an increased risk for conversion to dementia [7]. In this view, a few functional
[8] and structural neuroimaging investigations [9, 10] have attempted to clarify whether there
is a neurobiological substrate for BPSD in AD and MCI [10]. At least two of these studies
have found a strict association between the presence of specific BPSD and the severity of grey
matter (GM) atrophy in brain areas typically affected by AD pathology [9,10]. In detail, GM
atrophy involving the fronto-parietal regions was found to be associated with apathy and agi-
tation [9], while atrophy of the anterior cingulate cortex was found associated with disinhibi-
tion [10].
On the other hand, white matter (WM) tissue damage is also known to occur in AD
pathophysiology and to partially account for patient clinical features [11]. Several previous
studies, based upon quantitative magnetic resonance imaging (MRI) techniques, have detected
the presence of microscopic WM changes, which in some cases correlated with patients’ mea-
sures of cognitive decline [12,13]. In patients with neurodegenerative dementia, the presence
and extent of macroscopic WM lesions is usually larger than in healthy elderly individuals
[14]. The pathological substrate underlying these macroscopic lesions still remains under de-
bate, and two major hypotheses have been proposed so far. According to the first hypothesis,
WM lesions might reflect the occurrence of cerebrovascular comorbidity [15]; whereas accord-
ing to the second they might be due to cerebral amyloid angiopathy [16]. Regardless of the
pathophysiological substrate of WM lesions, it is conceivable that they might contribute to
determining some patients’ clinical features when their anatomical localization is within
strategic areas. There are several methods to assess the anatomical distribution and severity
of WM lesions, and to correlate them with clinical variables. One useful approach, called
voxel-lesion-symptom mapping (VSLM) [17] allows, after detection of WM lesions, to associ-
ate their anatomical localization with patients’ clinical, neuropsychological and behavioural
measures. VSLM has already been successfully used in patients with stroke [18] and brain inju-
ry [19].
The aim of this study was to assess, using VSLM, whether specific anatomical localizations
of macroscopic WM lesions might contribute to determining BPSD in patients with a-MCI.
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Methods and Materials
Subjects and experimental procedure
A cohort of 31 patients responding to the diagnostic criteria for amnestic MCI [1] (15 of them
with a-MCI single domain and 16 with a-MCI multiple domain) was consecutively recruited
from the Specialist Dementia Clinic of Santa Lucia Foundation (Table 1). All MCI patients in-
cluded here belong to a larger consecutive population participating in a longitudinal, ongoing
study, with clinical and neuropsychological follow-up regularly performed at six monthly in-
tervals plus or minus 2 weeks, over 2 years. At the time of recruitment a-MCI patients (both
single and multiple domain) had to report subjective memory impairment at clinical onset,
corroborated by an assistant and confirmed by performances below the cut-off scores of nor-
mality on at least one of the administered tests for episodic memory (see Table 2). Additionally,
patients with a-MCI multiple domain had to report pathological scores in at least one cognitive
function different from memory. By definition, all MCI patients had not to fulfill the Diagnos-
tic and Statistical Manual of Mental Disorders (DSM-IV) criteria for the diagnosis of dementia
[20], their MMSE score [21] had to fall above the cut-off for normality (>23.8), and their Clini-
cal Dementia Rating score (CDR) [22] score had to be equal to 0.5. At each follow-up, all pa-
tients received clinical and neuropsychological re-assessments. To increase the confidence of
including patients in a pre-dementia stage of AD [3], a clinical conversion to AD or an AD-
type progression of cognitive impairment had to be proven during follow-up. In the case of
“neuropsychological progression”, a-MCI patients single domain had to develop additional
deficits in the areas of visuospatial abilities and/or executive functions. Additionally, none
of the recruited patients had to develop remarkable language deficits, parkinsonism,
or fluctuations.
For each administered test appropriate adjustments for gender, age and education were ap-
plied according to the Italian normative data. Available cut-off scores of normality (> 95% of
the lower tolerance limit of the normal population distribution) are also reported for each test.
Within 3 days of recruitment, patients underwent neuropsychological and behavioural as-
sessments and an MRI scan. An extensive neuropsychological battery was used to define each
participant’s cognitive profile (Table 2), as previously described [10]. As detailed below, the as-
sessment of behavioural symptoms was performed, in patients only, by means of the Neuropsy-
chiatric Inventory-12 (NPI-12) [23]. Because the NPI-12 can only be used with patients, a
trained psychologist administered a clinical interview to the healthy participants in order to ex-
clude the presence of major behavioural disorders. With respect to the presence and severity of
Table 1. Principal characteristics of studied subjects.
a-MCI HS
N = 31 N = 26
Mean (SD) age [years] 71.3 (8.1) 67.5 (7.0)
F/M ratio 14/17 11/15
Mean (SD) MMSE 26.0 (1.6)* 28.6 (1.4)
Mean (SD) Hachinski score 1.3 (1.6) 0.8 (1.3)
Mean (SD) T2-lesion volume [mL] 3.8 (5.8) 1.6 (2.9)
Mean (SD) T2-lesion fraction 0.3 (0.4) 0.1 (0.2)
Abbreviations: a-MCI = amnestic Mild Cognitive Impairment; HS = healthy subjects; MMSE = Mini Mental
State Examination.
*a-MCI vs. HS p-value 0.05.
doi:10.1371/journal.pone.0124998.t001
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macroscopic WM lesions, there are no definite cut-off criteria available to discriminate be-
tween vascular and neurodegenerative dementia [15]. A certain overlap between neurodegen-
eration and vascular pathology is likely to characterize most patients responding to the
diagnostic criteria for MCI [3] and AD [24]. However, to reduce the risk of including patients
with vascular MCI as much as possible, principal comorbidities (i.e., diabetes, hypertension,
hyperlipidemia, arrhythmias) and risk factors (i.e., alcohol abuse) for developing cerebrovascu-
lar pathology were ruled out in all patients. Additionally, in every patient, the Hachinski score
[25] had to be less than 4. The Hachinski scale is a clinical tool often used to differentiate be-
tween AD and vascular dementia, with a cut-off score 4 being suggestive for AD-type de-
mentia, and a score 7 suggestive for Vascular Dementia. Moreover, we considered as
additional inclusion criteria a total WM lesion volume not exceeding 25 mL [15]. As explained
below, 26 healthy elderly volunteers (healthy subjects: HS) were also recruited as a control
group for neuropsychological and neuroimaging data (i.e., lesion load and distribution, GM
Table 2. Neuropsychological assessment.
Cognitive domain a-MCI HS
Neuropsychological test
Verbal episodic long-term memory
15-Words List:
Immediate recall (cut-off  28.5) 30.3 (6.1)* 45.3 (9.3)
Delayed recall (cut-off  4.6) 4.4 (2.3)* 9.4 (2.1)
Short story test:
Immediate recall (cut-off 3.1) 4.7 (1.4) 5.9 (1.5)
Delayed recall (cut-off  2.6) 3.7 (2.3)* 5.9 (1.3)
Visuo-spatial episodic long-term memory
Complex Rey's Figure:
Immediate recall (cut-off  6.4) 11.0 (6.9) 14.5 (7.6)
Delayed recall (cut-off  6.3) 9.9 (7.6) 14.6 (6.5)
Verbal short-term memory
Digit span (cut-off  3.7) 5.2 (0.9) 5.9 (1.1)
Visuo-spatial short-term memory
Corsi span (cut-off  3.5) 4.4 (0.5)* 5.0 (0.9)
Executive functions
Phonological Word Fluency (cut-off 17.3) 29.8 (6.0) 35.9 (8.7)
Mod. Card Sorting Criteria achieved (cut-off  4.2) 3.8 (1.9)* 5.7 (0.7)
Mod. Card Sorting perseverative errs. (cut-off 7.6) 6.3 (4.8) 4.8 (4.8)
Language
Naming of objects (cut-off  22) 28.4 (1.8) 29.1 (1.0)
Reasoning
Raven's Coloured Progr Matrices (cut-off  18.9) 27.7 (5.2)* 32.5 (2.7)
Constructional praxis
Copy of Complex Rey's Figure (cut-off  23.7) 29.6 (6.5) 33.0 (2.2)
Copy of drawings (cut-off  7.1) 9.5 (1.7)* 10.8 (1.2)
Copy of drawings with landmarks (cut-off  61.8) 66.3 (4.3) 69.4 (0.8)
(*) One-way ANOVA p-values Bonferroni’s corrected <0.003 (0.05/16)
Abbreviations: a-MCI = amnestic Mild Cognitive Impairment; HS = healthy subjects; Mod. = modiﬁed, errs.
= errors
doi:10.1371/journal.pone.0124998.t002
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volumetrics). In all HS, the presence of major systemic and neurological illnesses, cognitive def-
icits (assessed using the same neuropsychological battery used in the a-MCI population), and
behavioural disorders (assessed by clinical interviews) were carefully investigated and excluded.
Finally, to reduce any potential source of variability due to hemispheric dominance, all subjects
had to be right-handed (as assessed by the Edinburgh Handedness Inventory) [26]. Principal
demographic and clinical characteristics of all recruited subjects are summarized in Table 1.
Ethics statement
The Ethics Committee of Santa Lucia Foundation approved the study. Written informed con-
sent was obtained from all recruited subjects before study initiation.
Behavioural assessment
The Neuropsychiatric Inventory-12 (NPI-12) [23] was used to quantify the presence and sever-
ity of patients’ BPSD [7]. Briefly, this scale is a semi-structured inventory completed by the pa-
tients’ caregivers and designed to detect the following symptoms: delusions and hallucinations,
agitation/aggression, dysphoria/depression, anxiety, euphoria/elation, apathy, disinhibition, ir-
ritability/lability, aberrant motor behaviour, sleep and eating disturbances. Each item’s score
ranges from 0 to 12, and reflects both severity and frequency of each behavioural symptom,
with 0 corresponding to the absence of behavioural symptom and 12 corresponding to its max-
imum frequency and severity. The frequency rating multiplied by the severity rating produces
a score for each behavioural symptom. Consistent with Cummings [27], we applied (subject
by subject) the following cut-offs to consider BPSD as clinically relevant: for delusions, halluci-
nations, agitation, euphoria, apathy, aberrant motor behavior a score1; for irritability a
score 2; for disinhibition a score 4; for depression a score 6; Finally, although an NPI
cut-off score for clinically relevant anxiety has not been proposed by Cummings, we used a
score 4, as reported in a recent study [28].
Collinearity (i.e. patterns of co-occurrence or correlation) within BPSD was also assessed
across patients. In order to evaluate the interdependence between clinically relevant BPSD,
we reduced each NPI-12 subscale from continuous to categorical data (presence/absence of
symptoms) in accordance with the cut-off reported above. Therefore, each NPI-12 subscale
was correlated with each other by using rphi coefficient. To control for the I-type error we
used the Bonferroni Correction for multiple comparisons (statistical threshold = p<0.004
[α/n = 0.05/12]).
Spearman’s correlation coefficient was used to assess associations between clinically relevant
BPSD and neuropsychological scores (p value set at<0.003 after Bonferroni’s correction [α/
n = 0.05/16]).
Magnetic resonance imaging
All subjects underwent MRI scanning at 3T (Magnetom Allegra, Siemens, Erlangen, Germany),
including the following acquisitions: (1) Dual-echo turbo spin echo (TSE) (repetition time
[TR] = 6.190 ms, echo time [TE] = 12/109 ms, matrix = 256x192; FOV = 230x172.5mm2;);
(2) fast-fluid-attenuated inversion recovery (FLAIR) (TR = 8.170 ms, TE = 96 ms, inversion
time [TI] = 2.100 ms, same matrix and FOV as the TSE); (3) 3DModified-Driven-Equilibrium-
-Fourier-Transform (MDEFT) scan (TR = 1338 ms, TE = 2.4 ms, Matrix = 256x224x176, in–
plane FOV = 250x250 mm2, slice thickness = 1 mm).
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Assessment of macroscopic white matter lesions
T2-hyperintense lesions were first identified by consensus by two trained observers (M.T. and
B.S.) on TSE images. Then, lesions were outlined on the shortest echo TSE sequence using a
semi-automated local thresholding contouring technique (Jim 4.0. Xinapse System. Leicester.
UK. http://www.xinapse.com/). For each subject, global WM lesion volume and fraction were
calculated. WM lesion fraction is defined as global WM lesion volume divided by intra-cranial
volume (ICV). For each subject, ICV was derived by adding the volumes of each tissue segment
(WM, GM and CSF) obtained by voxel-based morphometry (VBM). WM lesion volumes and
fractions were both used to investigate potential associations with those neuropsychological
scores for which patients reported significantly different scores than HS, and patients’ BPSD
scores. Finally, WM lesion masks were used for VSLM analyses.
Voxel-lesion-symptommapping
To investigate the potential association between WM lesion distribution and neuropsychologi-
cal performance and occurrence/severity of BPSD in patients with a-MCI, we employed the
VLSM approach [17]. VLSM is a voxel-wise statistical method that allows a correlation be-
tween continuous clinical measures and lesion distribution on a voxel-by-voxel basis. In brief,
given a clinical variable of interest (e.g., anxiety NPI subscore), VLSM performs a series of T-
tests, one for each voxel included in patients’ lesions, based upon the presence or absence of
lesional tissue in each given voxel. This therefore allows the identification of those brain areas
whose damage (i.e., presence of macroscopic lesions) has the greatest impact on a certain clini-
cal variable (e.g., anxiety NPI subscore). To perform the VLSM analysis we firstly normalized
the lesion mask of every subject to Montreal Neurological Institute (MNI) space as follows.
The shortest echo TSE images (also used for lesion outline) was segmented into GM, WM and
CSF using SPM8-NewSegment [29]. We then added the three tissue probability maps to obtain
a probabilistic brain mask matching the TSE scan. This probabilistic brain mask was thre-
sholded and binarised, and used to skull-strip the original TSE image. The skull-stripped TSE
image was then affine transformed (using the tool FLIRT from FSL library, www.fmrib.ox.ac.
uk/fsl/) to match the template “MNI152_T1_1mm_brain” (a T1-weighted atlas in MNI coordi-
nates [30] available with FSL). The same transformation was then applied to the binary lesion
mask to finally get the lesion mask normalized to the MNI space. All NPI-12 scores with a
prevalence of at least 20% in our patient sample were entered as variables of interest in VLSM
analyses [17]. For each neuropsychological and behavioural variable taken into consideration,
the T-tests were confined to those voxels where at least 4 subjects had lesions in order to main-
tain a reasonable level of statistical power. The resulting statistical maps were corrected for
multiple comparisons at cluster level using permutation tests [31] with 1000 repetitions, ac-
cepting as significant p values of less than 0.05.
Brain Volumetrics
MDEFT scans were used for voxel-based morphometry (VBM) analysis according to the opti-
mized protocol implemented in SPM8 (http://www.fil.ion.ucl.ac.uk/spm/) [29]. Briefly, VBM
consists of an iterative combination of segmentations and normalizations to produce a GM
probability map [29,32] in MNI space for every subject. In order to compensate for compres-
sion or expansion which might occur during warping of images to match the template, GM
maps were “modulated” by multiplying the intensity of each voxel in the final images by the Ja-
cobian determinant of the transformation, corresponding to its relative volume before and
after warping [33]. GM, WM and CSF volumes were computed from these probabilistic images
for every subject. All data were then smoothed using a 12-mm FWHMGaussian kernel.
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Statistical analyses were finally performed on smoothed GMmaps within the framework of the
general linear model. An ANOVA full factorial design was first employed to compare regional
GM volumes between a-MCI patients and HS. A multiple regression was used to investigate
the potential association between global WM lesion and regional GM volume in patients only.
Further, two additional statistical models were respectively employed to assess associations be-
tween: 1) regional GM volumes and scores at neuropsychological tests for which a-MCI pa-
tients performed significantly worse than HS; 2) regional GM volumes and NPI-12 scores for
those BPSD found to be present in our patient cohort.
Finally, additional post-hoc ANOVA models were planned to test for potential regional GM
differences between sub-groups of patients with a WM lesion distribution associated to BPSD
according to VSLM.
In all VBM analyses, ICV, age and gender were entered as covariates of no interest. Statisti-
cal threshold was always set to p-values family-wise-error (FWE) corrected at cluster-level infe-
rior to 0.05.
Results
According to the inclusion criteria, there were no significant differences in age (F1, 55 = 3.47,
p = 0.067), gender distribution (Chi-square = 0.05, degree of freedom (dof) = 1; p = 0.82) and
Hachinski score (F1, 55 = 1.5, p = 0.022) between a-MCI patients and HS (Table 1). As expected,
a-MCI patients showed significantly lower MMSE scores than HS (F1, 55 = 34.2, p<10
–4). At
clinical follow-up, 10 of 31 patients (32%) converted to AD (according to the current diagnostic
criteria [34]), while 21 (68%) revealed the typical neuropsychological progression of AD as de-
fined in the methods. None of them reverted back to normality or converted to other forms
of dementia.
Neuropsychological and behavioral assessment
From a neuropsychological viewpoint, a-MCI patients (both single or multiple domain) re-
vealed impairment of episodic memory and executive functions (Table 2). According to the cri-
teria outlined in the Methods, the following scores were retained for correlating with GM
volume, WM lesion volume and VSLM analyses: Immediate and delayed recall of a 15 word
list; Delayed Recall of Short Story test; Raven’s Matrices; Corsi Span; Modified Card Sorting
Test and Copy of Drawings. In order to achieve a global significance level of 0.05, the threshold
for each test was set at p< 0.003, according to Bonferroni correction (0.05/16).
No significant associations were detected within BPSD. In addition no significant correla-
tion was found between BPSD and neuropsychological scores.
With respect to the clinical relevance of BPSD, 17 of 31 a-MCI patients (54.8%) were affect-
ed by apathy, 13 of 31 (41.9%) by irritability, 11 of 31 (35.5%) by depression, 9 of 31 (29.0%) by
anxiety, and 8 of 31 (25.8%) by agitation (Fig 1). As these 5 BPSD scores were used for correla-
tions with GM andWM lesion volumes and VLSM analyses, the threshold for each test’s statis-
tical significance was set at p< 0.01, according to Bonferroni correction.
WM lesions
Although the average lesion volume and fraction were higher in a-MCI patients compared to
HS (Table 1), this difference was not statistically significant (F1, 55 = 2.8, p = 0.099; and F1, 55 =
3.9, p = 0.053 respectively). The anatomical distribution of WM lesions was similar in the two
groups in periventricular areas (Fig 2), although with a greater extension in a-MCI patients.
No significant association was found between patients’WM lesion volume or fraction, and
neuropsychological and BPSD data.
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VLSM analysis
None of the neuropsychological scores for which patients performed significantly worse than
HS was found to be associated with WM lesion distribution by VSLM analyses.
Conversely, a significant association with WM lesion localization in the anterior thalamic
radiation (ATR) bilaterally was only found for the NPI-12 apathy score (Table 3 and Fig 3,
panel A) only. By using VLSM no other significant associations were found between WM le-
sions and the remaining NPI-12 subscales.
The table shows the areas of white matter lesions found to be correlated with the apathy
score by voxel lesion-symptom mapping (VLSM). For each cluster, peak statistics and coordi-
nates are reported. The between groups T-contrast was thresholded with p values<0.05, after
correcting for multiple comparisons at cluster level using permutation test. Each region size is
expressed as number of voxels. The white matter regions were assigned using JHU-White Mat-
ter Tractography Atlas, available in FSL [35]. T-score refers to the value at relative maximum.
The significant WM tracts were labelled as belonging to ATR by using the JHU-White Mat-
ter Tractography Atlas [35], available in FSL (http://fsl.fmrib.ox.ac.uk/fsl/fslwiki/). No other
significant associations were found. The voxels found to be significantly associated with apathy
in patients were also compared with the lesion distribution in HS (Fig 3, panel B), showing no
overlap. The two patient subgroups (with and without apathy) were then compared to each
other and against HS in all demographic, clinical, and neuroimaging variables. No significant
difference was observed between any group (apathetic a-MCI, non-apathetic a-MCI, and HS)
for age (F2,54 = 1.74, p = 0.19), gender (apathetic a-MCI vs. HS: Chi-square = 0.31, dof = 1,
p = 0.58; non-apathetic a-MCI vs. HS: Chi-square = 0.07, dof = 1, p = 0.79; apathetic vs. non-
apathetic a-MCI: Chi-square = 0.05, dof = 1, p = 0.82) or Hachinski score (F1,28 = 4.04,
Fig 1. Behavioural disorders and psychological symptoms in amnestic mild cognitive impairment patients. Histograms represent the percentage of
amnestic mild cognitive impairment (a-MCI) patients exhibiting each symptom assessed by the Neuropsychiatric Inventory 12 (NPI-12). Abbreviation: Mot.
Ab. Behav. = motor aberrant behavior.
doi:10.1371/journal.pone.0124998.g001
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p = 0.054). The neuropsychological assessment did not reveal any significant difference be-
tween apathetic and non-apathetic a-MCI patients. In the clinical follow-up the conversion
rate to AD was similar in apathetic (6/17) compared non apathetic (4/14) a-MCI patients (Chi-
square = 0.16, dof = 1, p = 0.69). WM lesion volume and fraction were also similar among
all groups.
Fig 2. Lesions frequency distribution map in patients (A) and controls (B). Colours represent number of subjects with a lesion to a specific voxel.
Warmer areas indicate areas of greater lesion overlap. The anatomical distribution of T2-hyperintense white matter lesions was similar between amnestic
mild cognitive impairment (a-MCI) patients (panel A) and controls (panel B). The between-group difference in T2-lesion volumes was not statistically
significant, although it was on average slightly larger in the patient group (see also Table 1).
doi:10.1371/journal.pone.0124998.g002
Table 3. Relationship between apathy andWMLs in the a-MCI group as assessed by VLSM.
White matter region Side Cluster size MNI coordinates of
max
T-score
x y z
Anterior thalamic radiation R 341 24 17 16 4.67
Anterior thalamic radiation L 80 -22 5 23 5.04
Abbreviations: R = right; L = left; max = relative maximum.
doi:10.1371/journal.pone.0124998.t003
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GM volumetrics
When comparing all a-MCI patients to controls, the typical pattern of GM loss dominated by
medial temporal lobe atrophy was found (Fig 4).
There was no significant association found between global WM lesion volume and regional
GM volumes in patients. Moreover, no significant association was found between regional GM
volumes and either neuropsychological or NPI-12 scores in a-MCI patients. Finally, a direct
comparison between a-MCI patients with and without apathetic symptoms (the most frequent
BPSD in our patient sample) did not reveal any significant difference in regional GM volumes.
Discussion
In this work, we recruited a consecutive group of patients with a clinical diagnosis of a-MCI
due to AD [3]. According to the inclusion criteria, a third of them converted to AD over
two years, whilst the remaining ones had a typical neuropsychological evolution for AD. Addi-
tionally, patients’ regional pattern of GM loss was consistent with that expected for a-MCI
Fig 3. Results of voxel lesion-symptommapping analyses. A significant association was found between the anatomical localization of white matter lesion
in the anterior thalamic radiation (areas in red) and the presence/severity of apathy in between amnestic mild cognitive impairment (a-MCI) patients (panel A).
Voxels in green show the lesion distribution in patients used for the voxel lesion-symptommapping (VSLM) analysis, i.e., only including areas where at least
4 subjects presented a lesion. The lesion distribution in healthy controls (panel B, in blue), does not overlap with the area found to be significant for apathy in
patients. Note that the lesion distribution is thresholded to show only voxels where at least 4 participants had a lesion, in order to match those included in the
VLSM analysis.
doi:10.1371/journal.pone.0124998.g003
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patients according to previous literature [36]. It is well established that macroscopic WM le-
sions increase progressively with aging [37] and are more likely to occur in the presence of de-
mentia [38]. The pathophysiological substrate of these lesions is still largely controversial.
Several previous studies have pointed out that vascular pathologies (e.g.: atherosclerosis, cere-
bral amyloid angiopathy) and Wallerian degeneration secondary to distal cortical atrophy can
often coexist [39–40]. Thus, it is likely that both neurodegenerative process and vascular insults
can contribute to injury of cerebral WM. Due to these uncertainties, setting a clear cut-off
purely based uponWM lesions volume to distinguish between vascular and neurodegenerative
forms of dementia would be too simplistic. In order to minimise the risk of including vascular
MCI patients, we ensured their Hachinski ischemic score was extremely low and not signifi-
cantly different on average from that of healthy controls. WM lesion loads and distribution
were also similar between patients and controls [38]. While we did not attempt to clarify the
pathological substrate, we hypothesised that WM lesions may contribute to determining brain
dysfunctions, especially when localised within strategic areas. In the current work we demon-
strated that the strategic localization of WM lesions in the anterior thalamic radiations is highly
associated with the occurrence and severity of apathy in combination with AD neurodegenera-
tion, but not of other BPSD or neuropsychological deficits. In support of this specific effect of
WM lesion distribution, the comparison of apathetic vs. non- apathetic a-MCI patients did not
reveal any other clinical, neuropsychological or brain volumetric difference.
Fig 4. Pattern of regional grey matter atrophy in all a-MCI patients compared to controls. There is shown here the pattern of regional grey matter loss in
all a-MCI patients compared to controls. Consistent to previous literature, atrophy was predominantly distributed to the medial temporal lobes. Statistical
threshold: p values family wise error corrected at cluster level < 0.05.
doi:10.1371/journal.pone.0124998.g004
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Apathy is a complex syndrome [41] due to direct [42] or indirect involvement of the pre-
frontal lobes [43], which can be due to either GM or WM damage. In AD patients, atrophy in
the anterior cingulate and prefrontal cortex [4,9] as well as WM lesions in the same areas [44]
have been found to be associated with apathy. Crucially, the cingulate cortex is strongly con-
nected to the mediodorsal nucleus of the thalamus [45], and disconnection within this circuit
has been shown to produce apathetic symptoms [46]. Consistent with this, our results indicate
that WM lesions induce apathy by disruption of fibres connecting the thalamus with prefrontal
regions. Prefrontal regions are part of a well-known cortico-subcortical network, which is in-
volved in the control of complex human behaviours [5]. Additionally, the anterior cingulate
gyrus is a key structure for the regulation of intentional and motivated behaviours [47]. We
identified here the bilateral damage of ATR as a strategic location for apathetic manifestations.
The ATR consists of fibres connecting mediodorsal and anterior thalamic nuclei to the pre-
frontal cortex and the anterior cingulate cortex [35].
We did not find any significant association between BPSD (i.e. apathy) and neuropsycho-
logical scores. This was unexpected because associations between apathy and executive func-
tions have been previously reported [48,49]. Our failure to detect a relationship in the present
study might possibly be explained by the fact that we used the NPI-12 to assess apathy. NPI-12
is a comprehensive tool to assess BPSD that does not allow for the investigation of distinct as-
pects of apathy (cognitive, motor and affective) [41]. Conversely, it is likely that the association
between executive functions and apathy is driven by the cognitive component of apathy [50],
which we were not able to isolate in the present study.
Interestingly, we did not find any association between BPSD and GM volume. In a previous
study, including both MCI and AD patients [10], we demonstrated a strict relationship be-
tween GM volume and positive BPSD, but no association with any negative symptom (includ-
ing apathy). This is somewhat unexpected, as atrophy of the pre-frontal areas has been
previously been implicated in apathy [51]. One of the possible explanations is that the patients
included in this study were all at a prodromal stage of AD. We therefore speculate that discon-
nection within the thalamo-cortical circuits (to which WM lesions contribute) might be ini-
tially responsible for apathy, whilst GM atrophy of the frontal lobes usually occurs at a later
stage, when more advanced neuropathological processes are likely to take place.
This is a preliminary and exploratory study and suffers from some limitations. First, we
only studied the relationship between lesion location and BPSD, and did not attempt to in-
vestigate the pathological substrate of those lesions. WM hyperintensities can reflect axonal
damage, demyelination, lacunar infarcts, and other forms of vascular damage [15]. It is pos-
sible that this these variable causes may result in different clinical manifestations. Consis-
tently, we observed a similar lesion distribution in patients and in HS who did not show any
BPSD. Although we did not find any overlap between the lesioned area significant for apathy
in patients and the lesion distribution in HS, further investigations, based upon quantitative
MRI techniques such as diffusion tensor imaging and magnetization transfer, are warranted,
in order to clarify this issue. A further limitation of this study on BPSD is the lack of differ-
entiation of apathy symptoms in sub-components, such as cognitive, motor and affective as-
pects [41]. Finally, the sample size of this study was relatively small for a VLSM analysis
[31]. However, the main consequence is to have a higher chance of false negative findings
(type II error), thus supporting the soundness of our results. In conclusion, this study con-
firms the relevance of WM lesions for some clinical manifestations of AD, since the early
phases. This data contributes to supporting the importance of disconnection syndrome,
which has been implicated in AD, and typically to explain some cognitive symptoms [52–
55]. Here we suggest that disconnection might also be relevant for some behavioural symp-
toms, namely apathy.
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